No conclusions can be drawn about medical cannabis for head and neck cancer due to extremely limited research | Research

The takeaway

A systematic review found only five studies on cannabis and head and neck cancer, none of which provided standardized dosing, making it impossible to draw conclusions about benefits or harms.

Head and neck cancer patients and survivors, otolaryngologists, oncologists

Only 5 studies exist on cannabis and head and neck cancer

What the researchers found

Only five studies met inclusion criteria, most investigating recreational rather than medical cannabis. Studies varied in quality and none reported standardized cannabis dosing. Meta-analysis was not possible due to variability in reported outcomes.

Why it matters

Head and neck cancer patients frequently deal with pain, nausea, and difficulty eating, all conditions where cannabis is commonly used. The almost complete absence of evidence is itself a significant finding.

The numbers in context

Only 5 studies met inclusion criteria; most studied recreational cannabis; only 1 study reported dosing; meta-analysis was not possible

How the study worked

Systematic review of PubMed, Embase, and Web of Science with no time limit, following standard methodology with two independent reviewers for screening and one for data extraction.

What this study cannot tell us

The absence of evidence does not prove absence of effect. The extremely limited literature prevented meaningful analysis. Publication bias may have excluded relevant data.

How to read the evidence

Systematic review limited by an extremely small evidence base with no standardized outcomes

When this study was published

Published in 2021. Research on cannabis for specific cancer types remains severely limited.

The bigger picture

This systematic review finding of almost no evidence highlights a pattern seen across many cancer types: patients are using cannabis for symptom management while clinicians have virtually no data to guide them.

Questions still open

Why has so little research been conducted on cannabis for this common cancer type? Would CBD-dominant products help with mucositis or other head and neck cancer-specific symptoms? What study designs would be most feasible for this population?

Common questions

Can cannabis help with head and neck cancer?

There is essentially no evidence to answer this question. A systematic review found only five relevant studies, none with standardized dosing, making it impossible to draw conclusions.

Why is there so little research?

Cannabis research faces regulatory barriers, and head and neck cancer specifically has received very little attention in cannabinoid studies. The lack of evidence does not mean cannabis is ineffective, only that it has not been properly studied.

Read the original research

Medical Cannabis as Adjunctive Therapy for Head and Neck Cancer Patients.

Cureus, 13(9), e18396

View on PubMed ↗Publisher’s paper ↗

Citation

Caputo, Mathew P; Rodriguez, Carmen S; Padhya, Tapan A; Mifsud, Matthew J. (2021). Medical Cannabis as Adjunctive Therapy for Head and Neck Cancer Patients.. Cureus, 13(9), e18396. https://doi.org/10.7759/cureus.18396